Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Vice President, Medical and Scientific Affairs, Takeda Pharmaceuticals North America, Inc.
Vice President, Clinical and Scientific Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.
Senior Vice President of Business Unit/Hospital Strategy, Roxane Laboratories, Inc.
Vice President, Medical Affairs, Roxane Laboratories, Inc.
Board-certified in oncology and hematology
Residency, Internal Medicine, Case Western Reserve University
Fellowship, Hematology and Oncology, University of Chicago Hospitals and Clinics